KIM CANTELLO-BAKER: Open Payments
NPI 1407296734 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,078 in 53 payments from 7 companies in 2025. Trend: 2023 $761 · 2024 $903 · 2025 $1,078
Food & beverage: $1,078
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $372 |
| Madrigal Pharmaceuticals | 11 | $349 |
| PFIZER INC. | 15 | $210 |
| Janssen Biotech, Inc. | 3 | $51 |
| Intercept Pharmaceuticals, Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
Products named: REZDIFFRA, LINZESS, RINVOQ, XELJANZ, VELSIPITY, SKYRIZI, TREMFYA, OCALIVA.
Industry payments across FL — which companies pay providers there.
